Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Sepsis Clinical Trials

106 recruiting trials for Sepsis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
106
Total Trials
106
Recruiting Now
9
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06646250

NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot

Non-invasive tools for monitoring of course of disease are important and necessary in the treatment of pre-term/premature infants and sick neonates. For many years, the ultrasound...

Sponsor: St. Olavs HospitalEnrolling: 1801 location
RECRUITINGNCT02143986

Glycosylated Ferritin in Macrophagic Activation Syndromes

In healthy subjects, from 50 to 80 % of the serum ferritin is glycosylated \[1, 2\] . A decrease in the percentage of ferritin glycosylation can be observed in inflammatory...

Sponsor: Brugmann University HospitalEnrolling: 601 location
RECRUITINGNCT06943326

Effects of Enteral Nutrition Content on Disease Progression in Sepsis Patients

The aim of this study was to investigate the effects of enteral nutrition content on disease progression in sepsis patients.

Sponsor: Inonu UniversityEnrolling: 601 location
RECRUITINGNCT00901602

Lebanese Interhospital Pneumococcal Surveillance Program

Streptococcus pneumoniae (pneumococcus) is a bacterium that causes severe infections in children and adults such as meningitis, pneumonia, and blood stream infection. There are...

Sponsor: American University of Beirut Medical CenterEnrolling: 7001 location
RECRUITINGNCT06476171

Validation of Hematological Indices

The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of...

Sponsor: Petrovsky National Research Centre of SurgeryEnrolling: 2001 location
RECRUITINGNCT05688774

Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases...

Pneumonia is a common infectious disease of the lung, often requiring treatment in the hospital. Clinical scoring systems are available, identifying patients not requiring...

Sponsor: Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe SepsEnrolling: 30010 locations
RECRUITINGNCT06692400

The Effects of Endotracheal Suctioning on Pain and Serum Markers

The goal of this experimental study is to understand if endotracheal tube (ETT) suctioning increases pain and causes stress on the body in intubated adult ICU patients. These...

Sponsor: Loma Linda UniversityEnrolling: 1101 location
RECRUITINGNCT06491966

Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis

This observational cohort study aims to compare clinical outcomes and inflammatory responses between patients with viral sepsis, specifically COVID-19-associated sepsis, and those...

Sponsor: Sichuan Provincial People's HospitalEnrolling: 3001 location
RECRUITINGNCT07022041

Sepsis and Hospital Mortality

Sepsis is one of the leading causes of hospital mortality, with a rate of approximately 20% (World Health Organization) among vulnerable patients admitted to high-intensity care...

Sponsor: University of CalabriaEnrolling: 1001 location
RECRUITINGNCT05304221

A Prospective Cluster-Randomized, Controlled Crossover Trial to Validate an Electronic "Resistance Calculator"

Primary objective: \- Our aim is to validate the "Shamir Resistance Calculator" in a prospective crossover trial, in order to shorten the time to initiation of appropriate...

Sponsor: Dror MarChaim, MDEnrolling: 15002 locations
RECRUITINGPhase 2NCT04803955

Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients

Phase II study of Kukoamine B Mesilate in Sepsis Patients

Sponsor: Tianjin Chasesun Pharmaceutical Co., LTDEnrolling: 4241 location
RECRUITINGEarly Phase 1NCT06882811

Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis

The primary objective: To evaluate the efficacy of intravenous infusion of universal UC-MSCs and CD83+MSCs subpopulation injection in the treatment of sepsis by using the 28-day...

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityEnrolling: 1801 location
RECRUITINGNCT06073834

LUNG INFECTION in ICU (LUNG-I3)

objective of LUNG-I3 study is to assess the quantitative and functional differences in cells between blood and bronchoalveolar lavage (BAL) fluid after an infection, with a...

Sponsor: BioMérieuxEnrolling: 681 location
RECRUITINGPhase 4NCT07004049

Optimising TREATment for Severe Gram-Negative Bacterial Infections

TREAT-GNB is an innovative trial to expedite the evaluation of various antibiotic choices and treatment strategies for severe multidrug-resistant Gram-negative bacterial...

Sponsor: National University of SingaporeEnrolling: 60020 locations
RECRUITINGNCT03948048

Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock

Severe sepsis and septic shock remain the leading causes of child mortality worldwide. Sepsis is a complex process that ultimately leads to circulation disorders, organ perfusion...

Sponsor: Children's Hospital of Fudan UniversityEnrolling: 601 location
RECRUITINGPhase 4NCT06471231

Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock

The aim of the present study is to verify whether the earlier association of vasopressin and norepinephrine, in patients in septic shock, determines variations in terms of use of...

Sponsor: Azienda Usl di BolognaEnrolling: 2641 location
RECRUITINGNCT07351344

African Survey on Sepsis Knowledge (ASK)

This study is an anonymous online survey on clinical knowledge of sepsis among healthcare professionals in seven countries in sub-Saharan Africa. The survey is to be repeated...

Sponsor: Claudia SpiesEnrolling: 3001 location
RECRUITINGPhase 2NCT06634069

Study SOLACE SEPSIS

A Pilot, Randomized, Double-Blinded, Controlled Study of Hemodynamic and Acid Base Effects of 0.5M Sodium Lactate and 3% Saline Solutions in Septic Shock Patients

Sponsor: University Hospital PilsenEnrolling: 401 location
RECRUITINGNCT07255105

Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China

In recent years, with the rapid advancement of medical technology and the rapid development of critical care medicine, the use of various central venous catheters in icus has been...

Sponsor: Jianfeng XieEnrolling: 18461 location
RECRUITINGNCT06772675

Vancomycin Reduction Practices (VRP) in the NICU

This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 1313 locations
RECRUITINGNCT05359601

Infusion Set Replacement Intervals for Critically Ill Patients

This study aimed to evaluate the efficacy of 24-hour versus 96-hour infusion set replacement to prevent central line-associated bloodstream infection (CLABSI) in critically ill...

Sponsor: Zhongnan HospitalEnrolling: 12401 location
RECRUITINGPhase 4NCT05148286

Albumin and Crystalloid Administration in Septic Shock

The current guideline emphasizes fluid resuscitation as the mainstay of initial management for septic shock. Albumin has the oncotic activity to maintain intravascular volumes...

Sponsor: Asan Medical CenterEnrolling: 24261 location
RECRUITINGNCT05912413

Predicton of Sepsis Recovery Performance Subtypes Pilot Study

This study addresses critically ill sepsis patients' current literature reports of ongoing post-hospital discharge weakness and hospital readmissions. This study is aimed at...

Sponsor: University of Alabama at BirminghamEnrolling: 401 location
RECRUITINGNCT06143137

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term...

Subjects previously enrolled / randomized in the ReActIF-ICE (Recovery from acute immune failure in septic shock by immune cell extracorporeal terapy - immune competence...

Sponsor: Artcline GmbHEnrolling: 1422 locations
RECRUITINGPhase 3NCT04292054

Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)

The indication of antibiotic prophylaxis in burn patients remains highly controversial and hasn't reached a consensus. The objective of antibiotic prophylaxis would be to reduce...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 5061 location
RECRUITINGPhase 4NCT05681442

Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

Patients hospitalized in ICU with sepsis (infection with life-threatening organ dysfunction according to sepsis 3.0 definitions) or septic shock presumably due to MDR-GNB...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 60020 locations
RECRUITINGNCT06103500

Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis

As antibiotic resistance increases globally, it becomes more difficult to select empiric antibiotic therapy, particularly in patients with sepsis who stand to benefit from early...

Sponsor: Ottawa Hospital Research InstituteEnrolling: 14403 locations
RECRUITINGNCT06833593

Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia

Prospective, multicenter, national, observational pharmacological study on the evaluation of efficacy of appropriate monotherapy vs combination treatment for non-complicated...

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 5104 locations
RECRUITINGNCT06499467

Norepinephrine Equivalent Dose of Vasopressin, Phenylephrine and Epinephrine in Septic Shock

Septic shock is the most common form of circulatory shock encountered in patients admitted in intensive care unit. The initial management involves fluid resuscitation but if...

Sponsor: Sanjay Gandhi Postgraduate Institute of Medical SciencesEnrolling: 1001 location
RECRUITINGNCT06537609

A Platform Trial for Gram Negative Bloodstream Infections

BALANCE+ is a perpetual multiple domain randomized controlled platform trial to evaluate various treatment strategies for Gram-negative bloodstream infections (GN BSIs). Each...

Sponsor: Sunnybrook Health Sciences CentreEnrolling: 250020 locations
RECRUITINGNCT06656104

Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections

The management of premature infants hospitalized in neonatal units requires the simultaneous intravenous (IV) infusion of several drugs and parenteral nutrition solutions, when...

Sponsor: Hospices Civils de LyonEnrolling: 4553 locations
RECRUITINGNCT06745115

Detection of Sepsis Occurrence by Using Blood Fluorescence

This study adopted a case-control study method to explore a reagent-free, highly sensitive, and frequently screened blood fluorescence metabolite analyzer for sepsis, which can...

Sponsor: Zhujiang HospitalEnrolling: 901 location
RECRUITINGNCT07096284

The PvCO2-PaCO2/CaO2-CvO2 Ratio in Septic Shock

The ratio of the venous-arterial carbon dioxide partial pressure difference to the arteriovenous oxygen content difference (Pv-aCO₂/Ca-vO₂) may be a marker of anaerobic metabolism...

Sponsor: Avicenna Military HospitalEnrolling: 303 locations
RECRUITINGNCT06657781

Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

: Sepsis, now defined as life-threatening organ dysfunction due to a dysregulated host response to infection, is an important global health problem representing about a fifth of...

Sponsor: Centre Hospitalier Universitaire de la GuadeloupeEnrolling: 1711 location
RECRUITINGPhase 3NCT05931601

Early Initiated Vasopressor Therapy in the Emergency Department

The goal of this pragmatic, multi-center, superiority, randomized clinical trial is to compare early treatment with peripheral (through a vein) infused noradrenaline (a natural...

Sponsor: Odense University HospitalEnrolling: 3208 locations
RECRUITINGNCT06680180

Fibrinolysis Resistance in Infection and Trauma

Blood coagulation disorders are often seen in critically ill patients e.g. with severe infection or following extensive injury, that can lead to life threatening events as a...

Sponsor: Anders AnemanEnrolling: 1504 locations
RECRUITINGPhase 2 / Phase 3NCT06694740

Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized...

The vast majority of serious clinical situations leading to intensive care (septic shock, polytrauma, acute cerebral aggression, major surgery) are characterized by significant...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1702 locations
RECRUITINGPhase 4NCT06726395

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

The goal of this study is to investigate if benzylpenicillin is a better treatment option than cloxacillin in patients with penicillin-susceptible Staphylococcus aureus...

Sponsor: Region SkaneEnrolling: 4201 location
RECRUITINGEarly Phase 1NCT06514339

Evidence-based Evaluation and Mechanism of Shenhuang Granules in the Treatment of Sepsis

Sepsis is a life-threatening organ dysfunction caused by the body's dysfunctional response to infection, most patients require treatment in the ICU, and is the leading cause of...

Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical UniversityEnrolling: 4101 location
RECRUITINGNCT07107685

Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care.

This is an observational, retrospective, multicenter study based on the use of demographic, clinical and biological data from deceased patients admitted between 2018 and 2022 to...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1501 location
RECRUITINGNCT05990491

Pituitary Function After Recovery From Septic Shock Among ICU Survivors

Prolonged circulatory shock is associated with marked disturbances in vascular supply to the brain, and endothelial dysfunction which can lead to disseminated intravascular...

Sponsor: Sanjay Gandhi Postgraduate Institute of Medical SciencesEnrolling: 902 locations
RECRUITINGNCT05659589

Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury

Acute kidney injury (AKI) is a frequent disease in conventional hospital departments and in intensive care units. It's associated with a high risk to develop chronic kidney...

Sponsor: Centre Hospitalier Universitaire, AmiensEnrolling: 1051 location
RECRUITINGNCT06234592

The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock

Acute kidney injury (AKI) is a common complication of septic shock and together these conditions carry a high mortality risk. In septic patients who develop severe AKI renal...

Sponsor: King's College Hospital NHS TrustEnrolling: 451 location
RECRUITINGNCT06720064

Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters

In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay...

Sponsor: Dokuz Eylul UniversityEnrolling: 401 location
RECRUITINGNCT07203833

Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock

Septic shock is the most severe form of infection. Currently, an early specific biomarker for septic shock is needed. Remember that shock situations are numerous, not only septic...

Sponsor: Centre Hospitalier Universitaire, AmiensEnrolling: 1441 location
RECRUITINGNCT06085690

Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science

The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on improvement...

Sponsor: Fudan UniversityEnrolling: 80501 location
RECRUITINGNCT07367113

Peripheral Perfusion Index-guided Fluid Resuscitation for Preventing Acute Skin Failure in Elderly Critically Ill...

This prospective, randomized, controlled trial aimed to evaluate whether fluid resuscitation guided by the Peripheral Perfusion Index (PPI) could reduce the incidence of Acute...

Sponsor: Ying WangEnrolling: 2161 location
RECRUITINGNCT06637904

TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections

A pre/post interventional use trial, with ED patients who are initially triaged to locations other than a dedicated patient room in the main ED (e.g., waiting room, hallway bed,...

Sponsor: InflammatixEnrolling: 3002 locations
RECRUITINGPhase 3NCT04910464

Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis

In this study, our aim is to investigate the role tranexamic acid in modulating inflammation in patients with sepsis.

Sponsor: Assiut UniversityEnrolling: 801 location
RECRUITINGNCT06860438

Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis

In this thesis we will use the current state of knowledge that PI can provide a reliable information about the state of peripheral microcirculation during the state of sepsis and...

Sponsor: Ain Shams UniversityEnrolling: 401 location

Showing 50 of 106 trials.Search all Sepsis trials

Frequently Asked Questions

There are currently 106 clinical trials for Sepsis, with 106 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Sepsis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 9 Phase 3 trials for Sepsis, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.